On July 6, 2020, the Board of Directors of Corbus Pharmaceuticals Holdings, Inc. upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed George S. Golumbeski, to serve as a member of the Board. Dr. Golumbeski will hold this position until the next annual meeting of the Company’s stockholders or until his successor is elected and qualified, subject to his earlier resignation or removal. Dr. Golumbeski is an independent biotechnology advisor since April 2018. From 2017 until April 2018, Dr. Golumbeski was the Executive Vice President for Innovation for Celgene Corporation, a biotechnology company, where he was previously Executive Vice President of Business Development since 2009, responsible for the full array of business development activities and focused primarily within the therapeutic areas of oncology and inflammation.